Phospholipase A2 expression in coronary thrombus is increased in patients with recurrent cardiac events after acute myocardial infarction

International Journal of Cardiology

Volumn 168, Issue 4, 2013, Pages 4214-4221

  Takahashi, Soichiro ^b   Suzuki, Koji ^b   Watanabe, Yosuke ^b   Watanabe, Kazuhiro ^b   Fujioka, Daisuke ^b   Nakamura, Takamitsu ^b   Obata, Jun Ei ^b   Kawabata, Kenichi ^b   Mishina, Hideto ^b   Kugiyama, Kiyotaka ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b NONE

Author keywords

Acute myocardial infarction; Atherosclerosis; Intracoronary thrombus; Phospholipase A2

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; PHOSPHOLIPASE A2;

ACUTE HEART INFARCTION; ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROMA; BARE METAL STENT; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY THROMBOSIS; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAVASCULAR ULTRASOUND; MALE; MONOCYTE; NEUTROPHIL; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECURRENT DISEASE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBOCYTE; THROMBUS ASPIRATION; TRANSLUMINAL CORONARY ANGIOPLASTY; AGED; ATHEROSCLEROSIS; BIOSYNTHESIS; ENZYMOLOGY; GENE EXPRESSION REGULATION; HEART CATHETERIZATION; HEART INFARCTION; INTRACORONARY THROMBUS; MIDDLE AGED; PHOSPHOLIPASE A(2); SUCTION;

ACUTE MYOCARDIAL INFARCTION; ATHEROSCLEROSIS; INTRACORONARY THROMBUS; PHOSPHOLIPASE A(2);

ADULT; AGED; CARDIAC CATHETERIZATION; CORONARY THROMBOSIS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PHOSPHOLIPASES A2; RECURRENCE; SUCTION;

EID: 84886306402     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.07.154     Document Type: Article

References (29)

1. V. Fuster, P.R. Moreno, Z.A. Fayad, R. Corti, and J.J. Badimon Atherothrombosis and high-risk plaque: part I: evolving concepts J Am Coll Cardiol 46 2005 937 954
2. K.P. Rentrop Thrombi in acute coronary syndromes: revisited and revised Circulation 101 2000 1619 1626
3. D.J. Fitzgerald, F. Wright, and G.A. FitzGerald Increased thromboxane biosynthesis during coronary thrombolysis. Evidence that platelet activation and thromboxane A2 modulate the response to tissue-type plasminogen activator in vivo Circ Res 65 1989 83 94
4. J.T. Willerson, P. Golino, J. Eidt, W.B. Campbell, and L.M. Buja Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications Circulation 80 1989 198 205
5. S. Cook, E. Ladich, and G. Nakazawa Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis Circulation 120 2009 391 399
6. Y. Hoshiba, K. Hatakeyama, T. Tanabe, Y. Asada, and S. Goto Co-localization of von Willebrand factor with platelet thrombi, tissue factor and platelets with fibrin, and consistent presence of inflammatory cells in coronary thrombi obtained by an aspiration device from patients with acute myocardial infarction J Thromb Haemost 4 2006 114 120
7. K. Nishihira, A. Yamashita, T. Ishikawa, K. Hatakeyama, Y. Shibata, and Y. Asada Composition of thrombi in late drug-eluting stent thrombosis versus de novo acute myocardial infarction Thromb Res 126 2010 254 257
8. P.J. Cannon Eicosanoids and the blood vessel wall Circulation 70 1984 523 528
9. 2 research: from cells to animals to humans Prog Lipid Res 50 2011 152 192
10. B.B. Boyanovsky, and N.R. Webb Biology of secretory phospholipase A2 Cardiovasc Drugs Ther 23 2009 61 72
11. 2 regulation of arachidonic acid mobilization FEBS Lett 531 2002 2 6
12. Y. Kita, T. Ohto, N. Uozumi, and T. Shimizu Biochemical properties and pathophysiological roles of cytosolic phospholipase A2s Biochim Biophys Acta 1761 2006 1317 1322
13. 2 Prostaglandins Leukot Essent Fatty Acids 69 2003 87 97
14. K. Thygesen, J.S. Alpert, and H.D. White Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction Circulation 116 2007 2634 2653
15. S.J. Nicholls, A. Hsu, and K. Wolski Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome J Am Coll Cardiol 55 2010 2399 2407
16. K. Kugiyama, Y. Ota, and K. Takazoe Circulating levels of secretory type II phospholipase A(2) predict coronary events in patients with coronary artery disease Circulation 100 1999 1280 1284
17. T. Yano, D. Fujioka, and Y. Saito Group V secretory phospholipase A2 plays a pathogenic role in myocardial ischaemia-reperfusion injury Cardiovasc Res 90 2011 335 343
18. Y. Saito, K. Watanabe, and D. Fujioka Disruption of group IVA cytosolic phospholipase A(2) attenuates myocardial ischemia-reperfusion injury partly through inhibition of TNF-α-mediated pathway Am J Physiol Heart Circ Physiol 302 2012 H2018 H2030
19. D. Fujioka, Y. Saito, and T. Kobayashi Reduction in myocardial ischemia/reperfusion injury in group X secretory phospholipase A2-deficient mice Circulation 117 2008 2977 2985
20. J.S. Kim, J.S. Kim, and T.H. Kim Comparison of neointimal coverage of sirolimus-eluting stents and paclitaxel-eluting stents using optical coherence tomography at 9 months after implantation Circ J 74 2010 320 326
21. M. Yamamoto, M. Takano, and D. Murakami Impact of small thrombus formation in restenotic bare-metal stent lesions associated with acute coronary syndrome: identification by optical coherence tomography Int J Cardiol 149 2011 169 173
22. R.D. Rudic, D. Brinster, and Y. Cheng COX-2-derived prostacyclin modulates vascular remodeling Circ Res 96 2005 1240 1247
23. A. Maehara, G.S. Mintz, and A.B. Bui Morphologic and angiographic features of coronary plaque rupture detected by intravascular ultrasound J Am Coll Cardiol 40 2002 904 910
24. D.J. Mancuso, D.R. Abendschein, and C.M. Jenkins Cardiac ischemia activates calcium-independent phospholipase A2beta, precipitating ventricular tachyarrhythmias in transgenic mice: rescue of the lethal electrophysiologic phenotype by mechanism-based inhibition J Biol Chem 278 2003 22231 22236
25. M.C. Morice, P.W. Serruys, and J.E. Sousa A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 346 2002 1773 1780
26. S.J. Nicholls, M.A. Cavender, and J.J. Kastelein Inhibition of secretory phospholipase A(2) in patients with acute coronary syndromes: rationale and design of the vascular inflammation suppression to treat acute coronary syndrome for 16 weeks (VISTA-16) trial Cardiovasc Drugs Ther 26 2012 71 75
27. Press release Anthera Pharmaceuticals Inc. Available at http://investor.anthera.com/releasedetail.cfm?ReleaseID=656340 [Accessed 9 March 2012]
28. 2 isoforms in the checkpoint control of acute inflammation FASEB J 18 2004 489 498
29. 2 activities for the treatment of inflammatory conditions Biochim Biophys Acta 1761 2006 1373 1382